Company: LBRX
Filing Date: 2025-09-08
Form Type: S-1/A
Source: 0001193125-25-197877
Chunk: 322

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-08
Form: S-1/A
Chunk 322
---
 L.P. and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the 
 sole managing member of TCG Crossover GP II, LLC and may be deemed to share voting, investment and dispositive power with respect to these securities. Dr. Yu disclaims beneficial ownership over the shares held by TCG Crossover Fund II, L.P.,       
 except to the extent of his pecuniary interest therein. The business address for TCG Crossover GP II LLC, TCG Crossover Fund II, L.P. and Dr. Yu is 245 Lytton Ave., Suite 350, Palo Alto, CA 94301.                                                    |

| (5) | Consists of (i) 69,658 shares of common stock beneficially held by Mr. Prensky, (ii) 492 shares of common                                                                                                                                     
 stock issuable upon conversion of shares of our redeemable convertible preferred stock beneficially held by Mr. Prensky, (iii) warrants to purchase up to 246 shares of common stock beneficially held by Mr. Prensky, and (iv) 30,747 shares 
 of common stock issuable upon the exercise of options held by Mr. Prensky that are exercisable within 60 days of June 30, 2025.                                                                                                               |

| (6) | Consists of shares of common stock issuable upon the exercise of options held by Mr. Sawhney that are 
 exercisable within 60 days of June 30, 2025.                                                          |

| (7) | Consists of (i) 3,585 shares of common stock and (ii) 15,276 shares of common stock issuable upon the exercise 
 of options held by Dr. Eramo that are exercisable within 60 days of June 30, 2025.                             |

| (8) | Consists of shares of common stock issuable upon the exercise of options held by Mr. Garland that are 
 exercisable within 60 days of June 30, 2025.                                                          |

| (9) | Consists of (i) 2,365 shares of common stock and (ii) 6,318 shares of common stock issuable upon the 
 exercise of options held by Dr. Ruffolo that are exercisable within 60 days of June 30, 2025.        |

| (10) | Consists of (i) 87,284 shares